If ICOS already knew the half-life in the 1990s, why wasn't Cialis 5 mg a daily tablet in 2003?
A 5 mg as-needed chip sat in the 1999-2001 matrix
Start with the milligram that was actually assigned before sex. Cialis 5 mg PRN was not a leftover crumb from a later daily program. It was a fixed as-needed arm while the molecule was still IC351.
April 1999 through April 2001: five randomized, double-blind, placebo-controlled trials at 74 centers. Men swallowed a coded tablet before anticipated activity. No food lecture. No alcohol lecture. The assigned strengths were 2.5, 5, 10, and 20 mg. One hundred fifty-one men drew the 5 mg chip. That is a PRN cell. It is not a breakfast series.
Sponsors put a lower as-needed step in a matrix when they expect some men to flush, ache, or overshoot on 10 or 20 mg. They also put it there when they want a labeled down-titration after launch. Both motives fit. What does not fit is rewriting that cell as a 2008 once-daily starter. The protocol said before intercourse. The diary said after the attempt. Nobody asked those 151 men to take an almond with oatmeal.
This site's method on a history page is short. Mark the first labeled job for the milligram. Name the dose (Cialis 5 mg PRN). Read the thread from Bothell to the carton. The tadalafil compound card keeps the finished rows. This essay is why the 5 mg night tablet existed before anyone funded a daily question.
If a slide says 5 mg and stays silent on schedule, send the slide back. The stamp is cheap to print. The contract is not. As-needed 5 mg is a smaller peak on a planned night. Daily 5 mg is a trough you maintain on purpose. Bothell built the first one first.
Bothell's IC351 was a slow scaffold, not a breakfast plan
ICOS Corporation sat in Bothell, Washington, and screened cardiovascular chemistry. The hit coded IC351 is a beta-carboline, not a sildenafil look-alike. Early animal and human PK already showed a long tail - mean terminal half-life later published near 17.5 hours. That is the discovery. A long tail makes a wide as-needed window thinkable. It does not automatically write a 30-day habit.
Plenty of slow drugs never become lifestyle breakfast tablets. Tadalafil became a PRN brand because the tail covered the next calendar day after a single swallow. Daily dosing is a second use of the same clearance. Second uses need second protocols. Residents who collapse those sentences treat 2003 and 2008 as one launch. They were not.
Phase I work on IC351 started in the mid-1990s. Phase II in men with ED opened in 1997, while Pfizer was already racing sildenafil to a 1998 US approval. ICOS did not get to invent the oral PDE5 class. It got to finish a slower member. The commercial question in those years was simple: can a man swallow once and stop treating Friday as a ninety-minute appointment?
A cheap morning script was not on that whiteboard. Daily steady state only makes sense after you trust the half-life in humans and after you prove low milligrams beat placebo without a pre-sex bolus. The first job was to beat the short clock on a single on-demand swallow. Cialis 5 mg PRN is a child of that job - the low rung on an as-needed ladder, not a rehearsal for toast.
Glaxo walked; Lilly ICOS filed a PRN NDA
A small biotech can find a slow scaffold. It cannot file a global NDA alone. The cap table explains the carton. It does not change how you swallow 5 mg tonight.
Glaxo Wellcome had a 1991 partnership with ICOS and a profit split on whatever came out of the screen. In 1996 Glaxo let the deal lapse. ED was not a core Glaxo market on their board papers. ICOS kept the 1994 patent family and the early human work. That walk is why Cialis is not a Glaxo heirloom.
Eli Lilly formed Lilly ICOS LLC in 1998, the same year Viagra proved someone would pay for an oral PDE5 tablet. ICOS kept chemistry and early development. Lilly brought sites, biostatistics, regulatory writers, and a launch machine. Patients do not need the LLC paperwork. Clinicians should know the 5 mg PRN step was not an in-house Lilly synthesis from day one. It was a PK find a large shop finished.
The 2000 NDA asked for tadalafil as Cialis, as needed. The commercial strengths that mattered at launch were 10 and 20 mg, with 5 mg as the labeled lower PRN step. Nobody in that filing was requesting a 30-count almond for every morning. Sponsors file what they can prove. In 2000 they could prove on-demand IIEF and SEP movement. They could not yet hand FDA a 24-week once-daily package.
Lilly bought ICOS outright in 2007, once Cialis revenue justified full ownership. By then the PRN brand was already old news and the daily supplement was in motion. Ownership trivia does not change a 5 mg as-needed swallow. It does explain why the breakfast tablet feels like a second product even though the INN never changed.
Brock assigned 151 men to 5 mg before sex, not before toast
Gerald Brock's integrated analysis (Journal of Urology, October 2002) is the public face of that matrix. Mean age 59. Mild to severe ED, mixed etiologies. Co-primaries: IIEF erectile-function domain, SEP2 (penetration), SEP3 (completed intercourse). A Global Assessment Question sat as extra. Food and alcohol were left unrestricted in the protocol language - a quiet contrast with the sildenafil plate lecture men already knew.
On 5 mg as needed, mean IIEF-EF rose 4.6 points versus 0.6 on placebo. SEP2 success improved 16 percentage points. SEP3 improved 22. GAQ improved-erection rate sat at 50 percent versus 35 percent on placebo. Those are PRN numbers. They sold a smaller night tablet for men who did not need, or did not tolerate, 10 or 20 mg. They did not sell a 30-day habit.
The 20 mg cell is the one ads later loved: +7.9 IIEF-EF, about 75 percent of attempts completed, 81 percent saying erections improved. Fine. Quote it as 20 mg. Do not drag those bars onto a 5 mg PRN blister and call the story the same. Dose-response was numeric in Brock. 5 mg cleared the statistical bar. It did not match the 20 mg peak. That is why the US label still starts most men at 10 mg and lets 5 mg be the step-down.
Porst's timed 36-hour work used 20 mg, not 5. Europe cleared tadalafil in late 2002. FDA followed on 21 November 2003. The US starting dose for most men was 10 mg before anticipated activity, with 20 mg as the usual uptitration and Cialis 5 mg PRN as the lower as-needed step. The 5 mg strength existed in the trial matrix as a night chip. It was not the launch identity, and it was not a daily identity.
November 2003 sold duration, and 5 mg as the step-down
Three oral PDE5 inhibitors shared one US calendar year: vardenafil earlier in 2003, tadalafil in November. Differentiation had to be immediate. Lilly's pitch was pharmacokinetic. One swallow, cover toward 36 hours, no greasy-plate penalty. That pitch names 10 and 20 mg. It mentions 5 mg as the man who flushed or overshot can step down. It does not mention a breakfast almond.
Why would it? Daily dosing looks like a compliance product. PRN looks like a night out. Marketing a long window is easier than asking a man to take a tablet on Tuesday when nobody is home. The science for daily was already whispering - 17.5-hour half-life, accumulation to a usable trough - but whispering is not a labeled row.
Renal and hepatic footnotes on the first label already used once-daily language for damaged clearance, which confuses readers later. That is a safety cap for people who cannot clear a PRN bolus, not the 2008 once-daily ED indication. Do not collapse those sentences. A 5 mg daily ceiling in moderate kidney disease is not Cialis 5 mg PRN for a healthy man who wants a smaller night peak.
The 2003 carton did one lasting job: it made duration the brand. Every later extension - daily ED, then BPH - rides that same slow elimination. If you want the IIEF receipt on the 5 mg as-needed cell, read what Brock's 5 mg PRN points actually bought. If you want the Portland split between a 5 mg night and a morning habit, read the 5 mg PRN versus daily almond review.
Daily 2.5 and 5 mg arrived in 2008 because someone funded a second question
Pharmacokinetics is a permission slip. It is not a stamp. Cialis 5 mg PRN did not secretly contain a breakfast protocol. Someone had to write one.
After an on-demand 10 or 20 mg swallow, tissue levels stay high enough for many men to respond the next calendar day. That is the 36-hour claim, not a hard cutoff. Effect tapers. Arousal is still required. PDE5 blockade only amplifies nitric oxide that sexual stimulation already released. A 5 mg PRN swallow uses the same enzyme story at a smaller peak.
The same slow clearance is why nitrate spacing stretches to about 48 hours after the last tablet, longer than the sildenafil-class habit of roughly a day. Convenience and monitoring move together. A Friday 5 mg that is still on board Saturday is also still on board if chest pain hits Sunday morning. Daily therapy makes that hold permanent for as long as the habit continues.
Forgue and colleagues later quantified what daily would look like: steady plasma levels by about five consecutive mornings, and about 1.6 times the exposure of the same milligram taken now and then. After those five days, a 5 mg habit behaves more like an 8 mg presence. Those are accumulation facts from 2006. The NDA is 2000. The dates refuse to collapse.
Rajfer-style once-daily trials had to exist before 8 January 2008, when FDA added 2.5 mg and 5 mg once daily for ED. The labeled daily start for most men is 2.5 mg at about the same time each day, with a rise to 5 mg if efficacy and tolerability allow. PRN 5, 10, and 20 mg stayed on the label. Two schedules. One INN. The 5 mg stamp now does two jobs. History says which job came first: Cialis 5 mg PRN.
The same 5 mg stamp later did prostate work - that is not PRN
FDA approved tadalafil for signs and symptoms of BPH, and for men who have both ED and BPH, on 6 October 2011. The dose for those urinary indications is 5 mg once daily. Cialis 5 mg PRN remains an as-needed ED step-down. Do not swap those sentences at the desk. Same ink on the tablet. Different question in the chart.
The BPH program used IPSS, not SEP diaries, as the primary urinary tool. Two BPH trials and one ED-plus-BPH trial enrolled 1,989 men. Only daily 5 mg carried the new indications. A man who uses 5 mg as needed for rare nights and later wants prostate cover usually needs a documented switch to a morning habit, not a hopeful reading of the PRN blister.
Alpha-blocker combinations for BPH symptoms are a separate caution. The label does not recommend stacking tadalafil with an alpha-blocker when the goal is urinary relief, because two vasodilating prostate strategies were not the studied pair. Solo daily tadalafil for overlap symptoms is the approved convenience. Dual hypotensive therapy for stream is not a free upgrade.
The development lesson is ugly and useful. Second movers win when they chase a dosing rhythm patients can live with, not a tighter IC50 on a poster. ICOS and Lilly chased duration. Daily and BPH fell out of that choice years later. Formulary committees still miss the lag and treat every 5 mg tablet as if it shipped as a breakfast product.
Portland point: the first labeled 5 mg was a night tablet
1993-1995
ICOS studies IC351 in Bothell. Phase I starts. Glaxo is still in the old partnership.
1996-1998
Glaxo walks. Viagra launches. Lilly ICOS LLC forms to finish tadalafil.
1999-2001
Five PRN trials run. 151 men are assigned 5 mg before sex, not before toast.
2000-2002
NDA filed as Cialis. Brock publishes the integrated as-needed package.
21 Nov 2003
FDA approves tadalafil for ED as needed. 5 mg is the labeled PRN step-down.
8 Jan 2008
FDA adds 2.5 mg and 5 mg once daily for ED - a second question, same INN.
6 Oct 2011
FDA adds BPH and ED-plus-BPH at 5 mg daily, not at 5 mg as needed.
Weekend pill is a fair counseling phrase for a Friday 20 mg. It is a sloppy phrase for Cialis 5 mg PRN if you let it erase the step-down job. 5 mg as needed is for the man who wants the long window at a smaller peak, or who stepped down after a 10 mg flush. It is not a secret daily. Mix those contracts and men skip the night tablet because they think they already took a breakfast dose last month - or they swallow a morning almond and call it PRN.
Priya's desk marks holds first. For this molecule the holds are nitrates (absolute), guanylate-cyclase stimulators (absolute), strong CYP3A4 inhibitors (PRN maximum 10 mg no more than once every 72 hours), and the 48-hour emergency gap after any last tablet. History does not relax those lines. It only tells you when each labeled row appeared.
Searchers who type buy or cheap next to Cialis 5 mg PRN are usually asking a history question in shopping clothes. The cheap tablet is generic tadalafil. The as-needed 5 mg schedule is a 2003 label fact. You cannot order the 2008 breakfast story and expect a PRN step-down to fall out of it. This page will not invent a cash price.
Point, then stop. Bothell built a 5 mg PRN Cialis before anyone asked for daily because the first oral PDE5 win was a short clock, because Lilly ICOS filed a PRN NDA, and because Brock's 5 mg cell was an as-needed arm. The milligram is small. The first job was a night. Daily was a later ask.
Reader mail
Reader questions on this article
Answered by Dr. Priya Raman, PharmD · Clinical pharmacology & drug safety
Mail on this history clustered on why a 5 mg night tablet existed before a morning habit. Priya answers the thread, not your chart. General language only.
Permission is not a file. A 17.5-hour half-life says a wide as-needed window is plausible, and it later made daily troughs thinkable. FDA still wanted a randomized, placebo-controlled as-needed package first. Brock's matrix - including 151 men on 5 mg before sex - is that package. Once-daily 2.5 and 5 mg needed a separate 24-week style program. Lilly ICOS also had a PRN brand to launch in 2003. Sponsors sequence what they can sell. I would not call the wait a conspiracy. I would call it an evidence queue. Bring the schedule question to your own clinician before you treat daily as a 2003 leftover.
Was the 5 mg strength just a leftover from the 20 mg weekend story?
No. Brock assigned a dedicated 5 mg as-needed cell. Mean IIEF-EF gain was 4.6 points versus 0.6 on placebo. SEP3 improved 22 percentage points. That is a real PRN result at a smaller peak. The 36-hour timed work that sold the weekend nickname used 20 mg. I use 5 mg PRN as a labeled step-down when 10 mg is too much peak or too much flush. I do not use it as a leftover crumb, and I do not use it as a breakfast dose unless the chart says once daily.
Does it matter to me that Glaxo walked and Lilly finished the drug?
Not for how you swallow tonight's generic. It matters if you assume every blockbuster is born inside one campus. ICOS spotted slow clearance in Bothell. Glaxo left in 1996. Lilly ICOS ran the late trials and the 2003 launch. Lilly bought ICOS in 2007. Cialis 5 mg PRN is a 2003 as-needed row on that stack. Genealogy does not change the nitrate hold or the CYP3A4 spacing. It does stop the myth that a 5 mg night tablet was Pfizer's idea with a new stamp.
I take a nitrate spray. Is a tiny 5 mg as-needed tablet a safer way to try Cialis?
No. Milligram size does not open the class ban. Organic nitrates plus any tadalafil schedule - Cialis 5 mg PRN or a 20 mg Friday or a daily almond - can drop blood pressure into an emergency. The 48-hour gap in the label is for a life-threatening case after a last dose, under monitoring, not a home timing trick. A 5 mg night tablet is still a last dose. Cardiology owns the chest-pain plan. I will not bless a workaround from a history thread.
Why do some write-ups say Europe had Cialis before the FDA?
Because they did. European approval landed in late 2002. FDA's date is 21 November 2003. That lag is routine regulatory traffic, not a different molecule. Both first labels were PRN identities. 5 mg as needed was already in that identity as the lower step. Daily 2.5 and 5 mg are still a later US supplement (2008). If an older relative remembers Cialis as a European weekend tablet, that memory is about the first carton, not about a breakfast 5 mg.
If I want both prostate symptoms and erections, should I stay on Cialis 5 mg PRN because this page locks 5 mg?
SERP lock is not a BPH dose. FDA's urinary indications (October 2011) use 5 mg once daily. Cialis 5 mg PRN is an as-needed ED step-down. Overlap ED-plus-BPH is a morning-habit conversation with your own clinician, plus a check that you are not stacking an alpha-blocker for the same stream. I will not point a prostate regimen from a history page. Read the compound card, then book the visit.
Why did three PDE5 tablets hit pharmacies around 2003 if Viagra already worked?
First-in-class success funds the pack. Sildenafil validated the target in 1998. Vardenafil and tadalafil were already in development. Their US arrivals clustered in 2003 because trial clocks converged, not because someone scheduled a parade. Patients gained a food-insensitive long window (tadalafil) and a tighter-binding short window (vardenafil). Prices fell later when generics arrived. Cluster launches are common after a proof-of-concept win. They are not evidence that a 5 mg breakfast existed in 2003.
Can I split a 20 mg tablet and call the fragment cheap Cialis 5 mg PRN?
I will not walk a splitting plan on a teaching desk. Scored or not, dose uniformity after a kitchen cut is a pharmacy problem, and 20 mg PRN tablets were not designed as a 5 mg factory. The labeled as-needed 5 mg product is a 5 mg tablet taken whole. Cost pressure is real. So is a crooked fragment that is not 5 mg. Ask the pharmacist who can see the actual stock. Do not treat a Bothell history essay as a coupon.
Where should I read next if I care about the numbers on that 5 mg night cell?
The trial essay walks Brock's +4.6 IIEF points, the placebo subtraction, and the nitrate door those 151 men never opened. The Portland split essay asks whether a 5 mg as-needed strip or a daily almond wastes fewer swallows on the month you actually live. This page's job is narrower: keep the 2003 night tablet from being rewritten as a 2008 breakfast. Education only. Your own clinician owns the schedule.
General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.
Last Updated